CN113797264A - Agilawood moxa stick for preventing and treating cardiovascular diseases - Google Patents

Agilawood moxa stick for preventing and treating cardiovascular diseases Download PDF

Info

Publication number
CN113797264A
CN113797264A CN202111202534.9A CN202111202534A CN113797264A CN 113797264 A CN113797264 A CN 113797264A CN 202111202534 A CN202111202534 A CN 202111202534A CN 113797264 A CN113797264 A CN 113797264A
Authority
CN
China
Prior art keywords
parts
agilawood
moxa
weight
moxa stick
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111202534.9A
Other languages
Chinese (zh)
Inventor
杨志文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Daguan Aloes Industry Development Co ltd
Original Assignee
Hainan Daguan Aloes Industry Development Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Daguan Aloes Industry Development Co ltd filed Critical Hainan Daguan Aloes Industry Development Co ltd
Priority to CN202111202534.9A priority Critical patent/CN113797264A/en
Publication of CN113797264A publication Critical patent/CN113797264A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • A61K36/835—Aquilaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A61H39/06—Devices for heating or cooling such points within cell-life limits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/02—Characteristics of apparatus not provided for in the preceding codes heated or cooled
    • A61H2201/0207—Characteristics of apparatus not provided for in the preceding codes heated or cooled heated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics

Abstract

The invention discloses an agilawood moxa stick for preventing and treating cardiovascular diseases, which comprises the following raw materials in parts by weight: 20-90 parts of agilawood, 10-80 parts of moxa, 1-20 parts of salvia miltiorrhiza, 1-20 parts of ginkgo leaves and 1-10 parts of saffron. The invention performs moxibustion on corresponding acupuncture points, the used medicine does not pass through intestines and stomach, has no toxic or side effect, and can effectively prevent and treat cardiovascular diseases caused by qi deficiency and blood stasis, such as coronary heart disease, hypertensive heart disease, rheumatic heart disease and the like.

Description

Agilawood moxa stick for preventing and treating cardiovascular diseases
Technical Field
The invention relates to the technical field of external traditional Chinese medicines, in particular to agilawood moxa sticks for preventing and treating cardiovascular diseases.
Background
According to traditional Chinese medicine, the meridians and collaterals are important channels for circulating qi and blood and connecting viscera and various parts of the body, and are the regulation and control system of human body functions. Therefore, the channels and collaterals are unobstructed, and qi and blood circulation is facilitated. Some cold-dampness pathogens often cause blockage of meridians, thereby inducing diseases. Moxibustion can dredge twelve meridians, enter three yin meridians and warm body acupoints and meridians, thereby activating collaterals, regulating blood and qi, and treating various diseases caused by congealing cold, blood stagnation and meridian obstruction. In the thousands of years of traditional Chinese medicine practice in China, moxibustion mainly has the effects of warming channels to dispel cold, promoting qi circulation to remove meridian obstruction, supporting yang to prevent collapse, lifting yang to lift sinking, drawing out toxin and discharging heat, preventing diseases and protecting health, and plays an important role in treating diseases and guaranteeing the health of people. However, in the current moxibustion therapy, no moxa roll which takes agilawood as a main drug and is matched with corresponding medicinal materials and aims at cardiovascular diseases such as coronary heart disease, hypertensive heart disease, rheumatic heart disease and the like is available.
Disclosure of Invention
Based on the technical problems in the background art, the invention provides an agilawood moxa stick for preventing and treating cardiovascular diseases.
The invention provides an agilawood moxa stick for preventing and treating cardiovascular diseases, which comprises the following raw materials in parts by weight: 20-90 parts of agilawood, 10-80 parts of moxa, 1-20 parts of salvia miltiorrhiza, 1-20 parts of ginkgo leaves and 1-10 parts of saffron.
Preferably, the feed comprises the following raw materials in parts by weight: 30-80 parts of agilawood, 20-70 parts of moxa, 3-15 parts of salvia miltiorrhiza, 3-15 parts of ginkgo leaves and 3-5 parts of saffron crocus.
Preferably, the feed comprises the following raw materials in parts by weight: 40-70 parts of agilawood, 30-60 parts of moxa, 10 parts of salvia miltiorrhiza, 10 parts of ginkgo leaves and 4 parts of saffron crocus.
Preferably, the feed comprises the following raw materials in parts by weight: 50-60 parts of agilawood, 40-50 parts of moxa, 10 parts of salvia miltiorrhiza, 10 parts of ginkgo leaves and 4 parts of saffron crocus.
Preferably, the method comprises the following preparation steps:
the method comprises the following steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use;
step two: drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use;
step three: mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder;
step four: adding lignum Aquilariae Resinatum, mixing with the pulverized medicinal fine powder, stirring to obtain mixture, and making into lignum Aquilariae Resinatum moxa stick by hand or with moxa stick maker.
According to the agilawood moxa stick for preventing and treating cardiovascular diseases, moxibustion is carried out on corresponding acupuncture points, the used medicine does not pass through intestines and stomach, so that no toxic or side effect exists, and cardiovascular diseases caused by qi deficiency and blood stasis, such as coronary heart disease, hypertensive heart disease, rheumatic heart disease and the like, can be effectively prevented and treated;
the agilawood has the effects of promoting qi circulation, relieving pain, dissipating with fragrance, warming and dispelling cold, regulating middle-jiao, tonifying five internal organs, replenishing vital essence and tonifying yang, has the characteristics of promoting qi circulation, not damaging qi, warming middle-jiao and not assisting fire, is matched with traditional Chinese medicines for promoting qi circulation, dredging collaterals, clearing heart fire, relieving restlessness, stimulating menstrual flow, relieving pain, promoting blood circulation, removing blood stasis, warming spleen and regulating qi, and has stronger targeted effect. For example, moxa is mainly used for treating spleen-kidney yang deficiency, red sage root can activate blood and dredge heart envelope, ginkgo leaf is mainly used for treating chest distress and cardiodynia, palpitation and severe palpitation, and saffron is mainly used for treating heart melancholia and depression, and dyspnea without dispersion. According to the characteristics of treating both principal and secondary aspects of diseases and combining medical treatment and maintenance in traditional Chinese medicine, the Chinese eaglewood moxa stick is scientifically and reasonably matched and utilized, and is mutually synergistic, so that the prepared Chinese eaglewood moxa stick has the remarkable effects of 'external internal treatment and medical treatment and maintenance combination', and can be used for pertinently treating cardiovascular diseases such as coronary heart disease, hypertensive heart disease, rheumatic heart disease and the like caused by 'qi deficiency and blood stasis'.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example one
The agilawood moxa stick for preventing and treating cardiovascular diseases comprises the following raw materials in parts by weight: 90 parts of agilawood, 10 parts of moxa, 20 parts of salvia miltiorrhiza, 20 parts of ginkgo leaves and 10 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use. Drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
Example two
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 80 parts of agilawood, 20 parts of moxa, 15 parts of salvia miltiorrhiza, 15 parts of ginkgo leaves and 8 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use. Drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
EXAMPLE III
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 70 parts of agilawood, 30 parts of moxa, 8 parts of salvia miltiorrhiza, 8 parts of ginkgo leaves and 5 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder with a grinder. And finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
Example four
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 60 parts of agilawood, 40 parts of moxa, 6 parts of salvia miltiorrhiza, 6 parts of ginkgo leaves and 4 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
EXAMPLE five
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 50 parts of agilawood, 50 parts of moxa, 5 parts of salvia miltiorrhiza, 5 parts of ginkgo leaves and 3 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
EXAMPLE six
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 40 parts of agilawood, 60 parts of moxa, 5 parts of salvia miltiorrhiza, 5 parts of ginkgo leaves and 3 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use. Mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
EXAMPLE seven
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 30 parts of agilawood, 70 parts of moxa, 3 parts of salvia miltiorrhiza, 3 parts of ginkgo leaves and 2 parts of saffron crocus.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
Example eight
The agilawood moxa stick for preventing and treating cardiovascular diseases is prepared from the following raw materials in parts by weight: 20 parts of agilawood, 80 parts of moxa, 1 part of salvia miltiorrhiza, 1 part of ginkgo leaf and 1 part of saffron.
The preparation method comprises the following specific steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; and finally, adding agilawood, putting the agilawood and the crushed medicine fine powder into a stirrer, uniformly stirring to form a mixture, and then manually or by using a moxa stick making machine to obtain the agilawood moxa stick.
The trial of more than 100 patients has achieved obvious effects, and the following are four application examples of the invention.
Application example 1:
in 47 years old, in Sunzhi, women often have angina pectoris in recent years, which is manifested by a feeling of squeezing behind the sternum, a feeling of oppression and distension, accompanied by significant anxiety, lasting for 3 to 5 minutes, often spreading to the left arm, shoulder, lower jaw, throat and back, and sometimes radiating to the right arm, and the hospital diagnoses coronary heart disease. The invention is used for moxibustion of Tanzhong, Yutang and Zigong for 30 minutes, and for moxibustion of Jueyinshu and Xinshu for 20 minutes, once a day, with 7 days of treatment course. The feeling is improved in the third day of the first treatment course, and after the moxibustion is finished and the rest is carried out for two days, the four treatment courses are repeated, so that the original symptoms are obviously improved. The patient usually uses the invention to carry out self-health care at home for more than 3 years, and the pain degree is light and can be quickly controlled although angina pectoris is occasionally caused.
Application example 2:
some people in Korean are 68 years old, and some people have been taking nifedipine hypotensor for hypertension for several years (high pressure is 150-160, low pressure is about 70). In 2019, when palpitation is suddenly felt in winter, the heartbeat is accelerated and strengthened, and the heart discomfort, full face and rising red, dizziness, nausea, weakness and the blood pressure rising to 190 (high pressure) are also accompanied. The hypertension heart disease is detected and diagnosed in a local three hospitals, doctors take the hypertension heart disease home only by changing a hypotensor (valsartan amlodipine tablet), after the patients take the hypertension heart disease, the blood pressure (high pressure) is maintained at 160-. By using the invention to moxibustion Zhongwan, Sanyinjiao, Guanyuan, Taichong, Geshu and Xinshu for 20 minutes, and giant que, dove tail, Yin Yang, Yang Lingquan and Shenshu for 30 minutes, after moxibustion is continuously carried out for two months (every five days with one day interval), the whole state is greatly improved, and the Chinese herbal medicine can cook rice, can reach downstairs and does not feel palpitation discomfort and dizziness and nausea. After moxibustion for three months, under the condition of not taking hypotensor, the measured high pressure is 140, the measured low pressure is 70, the physical strength is greatly enhanced, the sleeping condition is good, and various discomfortable feelings are basically disappeared.
Application example 3:
anzhi, a woman, 55 years old, before 12 years had a cold, manifested symptoms such as palpitation, dizziness, cough, etc., with mild and severe symptoms. The patient is judged to be the rheumatic heart disease after taking a chest radiograph in a hospital 5 years ago. Half a year before the cold, symptoms worsen with atrial fibrillation, chest distress, palpitation, poor sleep, more nightmare, sweating due to debility, low back pain, poor appetite, hypochondriac distention, hiccup, and cough and asthma. Irritability and susceptibility to cold, aggravated after each cold, and bedridden. By the invention, three days of 20 minutes each for the roasted mutton smelling, the epigastric region and the Kunlun are taken every day, so that the chest is comfortable, the appetite is good, and the people feel cold and cold due to carelessness, and have 39 body temperatures, cough, anorexia and hypodynamia. On the fourth day, the air door, Zusanli and Zhongwan were added for 20 minutes. By the seventh day, the body temperature was 37.8, the spirit was good, the cough was relieved, the abdomen was comfortable, and there was appetite. The breast root, Zusanli and Sanyinjiao are continuously moxibustion for 20 minutes respectively. On the tenth day, the body temperature was 36.9, and the cold was good. Then selecting acupuncture points such as moxibustion ventilation door, Feishu, Xinshu, Geshu, Ganshu, Danzhong, Qimen, Rugen, Juque, Chengman, Zhongwan, Xiawan, Tianshu, Qihai, Guanyuan, Tongli, Shenmen, Zusanli, Fuliu, Kunlun and the like according to symptoms every day. By every seventeen days, the patient has palpitation, improved cough, good diet, sleep and spirit, no longer dreams, better hiccups and asthenic perspiration and increased passing of qi. And the patient is allowed to return home for self-moxibustion once a day: mix-fried Zhongwan, Zusanli and navel for 30 minutes respectively on the 1 st time; moxibustion of lower abdomen, Qihai and Tianshu for 30 minutes respectively at the 2 nd time; 3, roasting Guanyuan and mammary root for 30 minutes, and carrying out Sanyinjiao for 25 minutes; roasting Xinshu and Tongli for 25 minutes respectively for 4 th time, and navel for 30 minutes, roasting Tianchi and Xinli for 25 minutes respectively for 5 th time, and navel for 30 minutes; roasting Geshu 25 minutes for the 6 th time, and 30 minutes respectively for the Danzhong, the Juque and the navel; the 7 th moxibustion of Ganshu and Qimen is carried out for 25 minutes respectively, and the navel is carried out for 30 minutes. And 8, the 8 th time of moxibustion for 25 minutes, and 30 minutes respectively for Kunlun and navel. The 8 times of circular moxibustion, and 25 minutes of moxibustion ventilation door and 25 minutes of Yanglingquan are added when people catch cold. After three cycles, the patient has few palpitations, sometimes none at one time in a day, and has little cough and less sputum, and has been relieved in two days to get black spherical hard stool (stagnation in the intestine is removed), which can be used in some housework. After 6 cycles, the patient feels that the heart chest is fast enough to reach the navel, and can go out to play without being hot and tired (the noise is not afraid of the important symptom of heart disease improvement). One year later follow-up, patients say: in autumn and winter, the patient has good physical quality and the subjective diseases are cured although the patient is cold in the day and does not catch a cold. Do work every day, hold housework, no longer have moxibustion.
The invention comprises the following steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use; drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use; mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder; adding lignum Aquilariae Resinatum, mixing with the pulverized medicinal fine powder, stirring to obtain mixture, and making into lignum Aquilariae Resinatum moxa stick by hand or with moxa stick maker.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (5)

1. The agilawood moxa stick for preventing and treating cardiovascular diseases is characterized by comprising the following raw materials in parts by weight: 20-90 parts of agilawood, 10-80 parts of moxa, 1-20 parts of salvia miltiorrhiza, 1-20 parts of ginkgo leaves and 1-10 parts of saffron.
2. The agilawood moxa stick for preventing and treating cardiovascular diseases according to claim 1, is characterized by comprising the following raw materials in parts by weight: 30-80 parts of agilawood, 20-70 parts of moxa, 3-15 parts of salvia miltiorrhiza, 3-15 parts of ginkgo leaves and 3-5 parts of saffron crocus.
3. The agilawood moxa stick for preventing and treating cardiovascular diseases according to claim 1, is characterized by comprising the following raw materials in parts by weight: 40-70 parts of agilawood, 30-60 parts of moxa, 10 parts of salvia miltiorrhiza, 10 parts of ginkgo leaves and 4 parts of saffron crocus.
4. The agilawood moxa stick for preventing and treating cardiovascular diseases according to claim 1, is characterized by comprising the following raw materials in parts by weight: 50-60 parts of agilawood, 40-50 parts of moxa, 10 parts of salvia miltiorrhiza, 10 parts of ginkgo leaves and 4 parts of saffron crocus.
5. The agilawood moxa stick for preventing and treating cardiovascular diseases according to claim 1, which is prepared by the following steps:
the method comprises the following steps: removing attached white wood from the agilawood raw material by using a hook knife, grinding the agilawood raw material into 100-mesh agilawood powder by using a low-speed grinding machine, and weighing the agilawood powder in parts by weight for later use;
step two: drying moxa, salvia miltiorrhiza, ginkgo leaves and saffron crocus in the sun, and weighing according to the parts by weight for later use;
step three: mixing moxa, radix Salviae Miltiorrhizae, folium Ginkgo, and stigma croci Sativi, and grinding into 100 mesh fine powder;
step four: adding lignum Aquilariae Resinatum, mixing with the pulverized medicinal fine powder, stirring to obtain mixture, and making into lignum Aquilariae Resinatum moxa stick by hand or with moxa stick maker.
CN202111202534.9A 2021-10-15 2021-10-15 Agilawood moxa stick for preventing and treating cardiovascular diseases Pending CN113797264A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111202534.9A CN113797264A (en) 2021-10-15 2021-10-15 Agilawood moxa stick for preventing and treating cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111202534.9A CN113797264A (en) 2021-10-15 2021-10-15 Agilawood moxa stick for preventing and treating cardiovascular diseases

Publications (1)

Publication Number Publication Date
CN113797264A true CN113797264A (en) 2021-12-17

Family

ID=78937754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111202534.9A Pending CN113797264A (en) 2021-10-15 2021-10-15 Agilawood moxa stick for preventing and treating cardiovascular diseases

Country Status (1)

Country Link
CN (1) CN113797264A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120448A (en) * 1994-10-13 1996-04-17 许木林 medicinal health handle
CN105998124A (en) * 2016-06-21 2016-10-12 陈铭鸿 Preparation technology of agilawood moxa stick
CN107213265A (en) * 2017-07-21 2017-09-29 王守东 The preparation method of smokeless argy wormwood agalloch eaglewood moxibustion and smokeless argy wormwood agalloch eaglewood moxibustion
CN112274423A (en) * 2020-11-11 2021-01-29 山东泰山本草科技开发有限公司 Medicinal moxa stick, using method, suspended moxibustion cylinder and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120448A (en) * 1994-10-13 1996-04-17 许木林 medicinal health handle
CN105998124A (en) * 2016-06-21 2016-10-12 陈铭鸿 Preparation technology of agilawood moxa stick
CN107213265A (en) * 2017-07-21 2017-09-29 王守东 The preparation method of smokeless argy wormwood agalloch eaglewood moxibustion and smokeless argy wormwood agalloch eaglewood moxibustion
CN112274423A (en) * 2020-11-11 2021-01-29 山东泰山本草科技开发有限公司 Medicinal moxa stick, using method, suspended moxibustion cylinder and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李晓雪: "艾叶在中医药和民族医药中的应用比较研究", 《亚太传统医药》 *
李涛: "银丹心泰滴丸治疗冠心病心绞痛68例临床疗效观察", 《山西医药杂志》 *

Similar Documents

Publication Publication Date Title
CN101259213B (en) Health drug pillow
CN101897755A (en) Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof
CN103494995A (en) Combination medicine for treating hypertension, hyperglycemia and hyperlipidemia
CN113797264A (en) Agilawood moxa stick for preventing and treating cardiovascular diseases
CN101406591B (en) Plaster for treating sore, carbuncle and painful swelling and preparation method thereof
CN102366469A (en) Drug for treating leucoderma
CN102614462A (en) Traditional Chinese medicine composition for curing coronary disease and preparation method thereof
CN105535456A (en) Traditional Chinese medicine formula for facial whitening and preparation method thereof
CN104398712A (en) Chinese medicinal preparation for treating facial spasm and preparation method
CN104173775A (en) Traditional Chinese medicine composition for treating cervicogenic headache and preparation method of traditional Chinese medicine composition
CN107252228A (en) It is a kind of to treat neurasthenia and the sedative health-care medicinal pillow of insomnia
CN105456951A (en) Traditional Chinese medicine preparation for treating breast fibroadenoma and preparing method of traditional Chinese medicine preparation
CN105012732A (en) Traditional Chinese medicine pill for treating sleep disorder syndrome and preparation method thereof
CN112316074A (en) Yao medicine Shujing foot bath agent and preparation method thereof
CN116688069A (en) A Chinese medicinal composition for treating facial acne, macula, and furuncle, and its preparation method
CN104491697A (en) Traditional Chinese medicine for treating cardiovascular neurosis
CN114533831A (en) Traditional Chinese medicine composition with effects of warming spleen and stomach for dispelling cold and eliminating dampness, and promoting blood circulation for removing obstruction in channels to relieve pain and fomenting bag thereof
CN102366613A (en) Chinese medicine composition for effectively treating leucoderma
CN111973690A (en) Moxibustion medicinal cake and preparation method thereof
CN108186953A (en) Foot-bathing health-care Chinese medicine composition and preparation method thereof
CN111870677A (en) Health-preserving foot soaking powder and preparation method thereof
CN112107620A (en) Pharmaceutical composition and application thereof in preparation of Du-moxibustion-dredging blocks
CN111298065A (en) Traditional Chinese medicine for invigorating spleen and tonifying kidney and preparation method thereof
CN110170013A (en) A kind of draft emulsifiable paste and preparation method thereof for treating wind-heat cough and asthma
CN110548080A (en) Traditional Chinese medicine composition for treating mammary gland lobular hyperplasia and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20211217